Ibu Zentiva 200 mg

Ibu Zentiva 200 mg is a medicine authorised by Swissmedic under authorisation number 67991. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 December 2021 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.

  • Dispensing category B
  • Authorisation number 67991
  • ATC M01AE01
  • Synthetic medicines
Authorisation data
Authorisation number67991
NameIbu Zentiva 200 mg
Full nameIbu Zentiva 200 mg, Filmtabletten
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM01AE01
First authorisation01 December 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ibu Zentiva 200 mg, FilmtablettenB01 December 2021
2Ibu Zentiva 400 mg, FilmtablettenB01 December 2021
3Ibu Zentiva 600 mg, FilmtablettenB01 December 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)M01AE0107.10.1.B
2100Tablette(n)M01AE0107.10.1.B
320Tablette(n)M01AE0107.10.1.B
450Tablette(n)M01AE0107.10.1.B
520Tablette(n)M01AE0107.10.1.B
6100Tablette(n)M01AE0107.10.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ibu Zentiva 200 mg authorised in Switzerland?

Yes. Ibu Zentiva 200 mg is authorised by Swissmedic under authorisation number 67991, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ibu Zentiva 200 mg have?

Ibu Zentiva 200 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ibu Zentiva 200 mg?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com